132 related articles for article (PubMed ID: 11495540)
1. Distribution of [3H]GR65630 binding in human brain postmortem.
Marazziti D; Betti L; Giannaccini G; Rossi A; Masala I; Baroni S; Cassano GB; Lucacchini A
Neurochem Res; 2001 Mar; 26(3):187-90. PubMed ID: 11495540
[TBL] [Abstract][Full Text] [Related]
2. Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.
Kilpatrick GJ; Jones BJ; Tyers MB
Eur J Pharmacol; 1989 Jan; 159(2):157-64. PubMed ID: 2707305
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
4. The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.
Kilpatrick GJ; Jones BJ; Tyers MB
Neurosci Lett; 1988 Nov; 94(1-2):156-60. PubMed ID: 3241663
[TBL] [Abstract][Full Text] [Related]
5. Effects of detergents on binding of 5-hydroxytryptamine3 receptor antagonist [3H]GR65630 to rat cortical membranes.
Inoue A; Tominaga Y; Nishio H; Segawa T; Nakata Y
Neurochem Int; 1993 Jun; 22(6):547-53. PubMed ID: 8513282
[TBL] [Abstract][Full Text] [Related]
6. Identification and distribution of 5-HT3 recognition sites within the human brainstem.
Barnes JM; Barnes NM; Costall B; Deakin JF; Ironside JW; Kilpatrick GJ; Naylor RJ; Rudd JA; Simpson MD; Slater P
Neurosci Lett; 1990 Mar; 111(1-2):80-6. PubMed ID: 2336196
[TBL] [Abstract][Full Text] [Related]
7. The distribution of 5-HT3 recognition sites in the marmoset brain.
Jones DN; Barnes NM; Costall B; Domeney AM; Kilpatrick GJ; Naylor RJ; Tyers MB
Eur J Pharmacol; 1992 Apr; 215(1):63-7. PubMed ID: 1516650
[TBL] [Abstract][Full Text] [Related]
8. Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.
Champaneria S; Costall B; Naylor RJ; Robertson DW
Br J Pharmacol; 1992 Jul; 106(3):693-6. PubMed ID: 1504752
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584.
Miller K; Weisberg E; Fletcher PW; Teitler M
Synapse; 1992 May; 11(1):58-66. PubMed ID: 1318585
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
11. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
[TBL] [Abstract][Full Text] [Related]
13. Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranes.
Hellevuo K; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 1991 Oct; 15(5):775-8. PubMed ID: 1755508
[TBL] [Abstract][Full Text] [Related]
14. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
15. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors.
Cubeddu LX; Bönisch H; Göthert M; Molderings G; Racké K; Ramadori G; Miller KJ; Schwörer H
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):85-91. PubMed ID: 10651152
[TBL] [Abstract][Full Text] [Related]
17. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
Lummis SC; Baker J
Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
[TBL] [Abstract][Full Text] [Related]
19. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
Ge J; Barnes JM; Towers P; Barnes NM
Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
Molderings GJ; Schmidt K; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
